Document is current
Any future updates will be listed below
-
Authors
Prajapati, Pintu
Rana, Bageshree
Pulusu, Veera Shakar
Shah, Shailesh
- License Information
-
More Information
Article History
Received: 31 July 2023
Accepted: 16 October 2023
First Online: 24 October 2023
Declarations
:
: Our research work does not include use of animal and human being. The present manuscript has been solely submitted to the Future Journal of Pharmaceutical Sciences. The authors have followed all ethical standards for publication processing.
: Our research work does not include any human study. The manuscript entitles ‘Method Operable Design Region for Robust RP-HPLC Analysis of Pioglitazone Hydrochloride and Teneligliptin Hydrobromide Hydrate: Incorporating Hybrid Principles of White Analytical Chemistry and Design of Experiments<b>’</b> has been solely submitted to Future Journal of Pharmaceutical Sciences.
: The authors of the manuscript already declared that they do not have any conflicts of interest for the publication of the manuscript.
